168 related articles for article (PubMed ID: 29197465)
1. ADDR Editor's Collection 2017.
Ghandehari H
Adv Drug Deliv Rev; 2017 Dec; 122():1. PubMed ID: 29197465
[No Abstract] [Full Text] [Related]
2. ADDR Editor's Collection 2019.
Ghandehari H
Adv Drug Deliv Rev; 2019; 151-152():1. PubMed ID: 31796165
[No Abstract] [Full Text] [Related]
3. ADDR Editor's Collection 2018.
Ghandehari H
Adv Drug Deliv Rev; 2018; 136-137():1. PubMed ID: 30514437
[No Abstract] [Full Text] [Related]
4. Editorial overview: Autoimmunity: A new frontier awaits.
Stetson DB
Curr Opin Immunol; 2018 Dec; 55():iii-iv. PubMed ID: 30522628
[No Abstract] [Full Text] [Related]
5. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.
Nakamura A; Akiyama K; Takai T
Expert Opin Ther Targets; 2005 Feb; 9(1):169-90. PubMed ID: 15757489
[TBL] [Abstract][Full Text] [Related]
6. Personalizing medicine for autoimmune and inflammatory diseases.
Chan AC; Behrens TW
Nat Immunol; 2013 Feb; 14(2):106-9. PubMed ID: 23334822
[TBL] [Abstract][Full Text] [Related]
7. The emerging therapeutic role of antibody mixtures.
Robak T
Expert Opin Biol Ther; 2013 Jul; 13(7):953-8. PubMed ID: 23646883
[TBL] [Abstract][Full Text] [Related]
8. Mast Cells as a Double Edged Sword in Immunity: Disorders of Mast Cell Activation and Therapeutic Management. Second of Two Parts.
Magrone T; Magrone M; Jirillo E
Endocr Metab Immune Disord Drug Targets; 2020; 20(5):670-686. PubMed ID: 31789136
[TBL] [Abstract][Full Text] [Related]
9. Updates in immune-based multiplex assays.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2019; 40(1):1-2. PubMed ID: 30632893
[No Abstract] [Full Text] [Related]
10. [New perspectives in immunotherapy: adhesion molecules, superantigens, heat-shock proteins and cytokine antagonists].
Gause A; Sahin U; Pfreundschuh M
Dtsch Med Wochenschr; 1992 Nov; 117(46):1764-73. PubMed ID: 1425297
[No Abstract] [Full Text] [Related]
11. ADDR Editor's Collection 2015.
Ghandehari H
Adv Drug Deliv Rev; 2015 Aug; 91():1-2. PubMed ID: 26349586
[No Abstract] [Full Text] [Related]
12. Therapeutic cleavage of IgG: new avenues for treating inflammation.
Nandakumar KS; Holmdahl R
Trends Immunol; 2008 Apr; 29(4):173-8. PubMed ID: 18328782
[TBL] [Abstract][Full Text] [Related]
13. Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools.
Jahromi LP; Shahbazi MA; Maleki A; Azadi A; Santos HA
Adv Sci (Weinh); 2021 Apr; 8(8):2002499. PubMed ID: 33898169
[TBL] [Abstract][Full Text] [Related]
14. Inflammation: the dynamic force of health and disease.
Vassileva V; Piquette-Miller M
Clin Pharmacol Ther; 2014 Oct; 96(4):401-5. PubMed ID: 25236660
[TBL] [Abstract][Full Text] [Related]
15. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease.
Boyman O; Surh CD; Sprent J
Expert Opin Biol Ther; 2006 Dec; 6(12):1323-31. PubMed ID: 17223740
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and cancer revisited: an hypothesis on the oncogenic potential of the apoptotic tumor cell.
Gregory CD
Autoimmunity; 2013 Aug; 46(5):312-6. PubMed ID: 23320865
[TBL] [Abstract][Full Text] [Related]
17. Are mimotope vaccines a good alternative to monoclonal antibodies?
Pourjafar M; Samadi P; Khoshinani HM; Saidijam M
Immunotherapy; 2019 Jun; 11(9):795-800. PubMed ID: 31094256
[TBL] [Abstract][Full Text] [Related]
18. The problem with potency.
Scott CT
Nat Biotechnol; 2005 Sep; 23(9):1037-9. PubMed ID: 16151384
[No Abstract] [Full Text] [Related]
19. Integrins and Their Role in Immune Cell Adhesion.
Dustin ML
Cell; 2019 Apr; 177(3):499-501. PubMed ID: 30952447
[TBL] [Abstract][Full Text] [Related]
20. The multi-subunit interleukin-2 receptor.
Waldmann TA
Annu Rev Biochem; 1989; 58():875-911. PubMed ID: 2673025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
